TQC2731
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for TQC2731, covering 2025-04-01 to 2025-12-12. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]